Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional, Prospective, Cross-sectional Study of Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Sars-Cov-2

NCT06601998 is registered in ClinicalTrials.gov with Hellenic Institute for the Study of Sepsis as lead sponsor.

NCT NCT06601998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06601998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional, Prospective, Cross-sectional Study of Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Sars-Cov-2
Lead sponsor
Hellenic Institute for the Study of Sepsis
Phase
Observational
Overall status
Recruiting
Start date
November 8, 2024
Completion date
June 8, 2028
Enrollment
650 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, covid-19 pneumonia, pneumonia, community-acquired